The global vaccine vials market is expected to reach USD 1589.46 million by 2030, at a CAGR of 13.21% from 2022 to 2030. Vaccine vials market growth would be driven by the increasing incidence of endemic infectious diseases. The rise in infectious diseases has led to increasing expenditure on the research and development of vaccines worldwide. The most recent example of this is the covid-19 pandemic and the rapid growth of vaccines to protect citizens against severe illness and death. The rise in research and development of vaccines will lead to an increase in demand for vaccine vials, thereby contributing significantly to the global vaccine vials market.

Market Overview:

A vaccine is a biological substance prepared in the laboratory which stimulates the production of antibodies and embodies the immune system to protect the host in case of future infections. A vaccine protects the body from severe illness and death. Vaccines are primarily prepared as a preventive measure to protect human life from bacterial and viral infectious/non-infectious diseases. It is designed by utilizing an agent of the bacteria or the virus which causes the diseases or other simulations which produce the same response from the immune system. Inactivated, live-attenuated, mRNA, toxoid, viral vector, and recombinant are various vaccine types. A vial can be defined as a storage unit and it is typically made of glass and it is small in size. It is cylindrical and is used to store liquid medicines. As the name suggests, Vaccine vials are vials used to store vaccines. The proper manufacturing of a vial is critical as vaccines must be stored within a particular temperature range. Vaccines vials must be chemically inert so they do not react with the material stored inside them. A vaccine vial is highly resistant to enzymes and moderated resistant to temperature changes. However, vaccine vials are also prone to breakage during transfer or heat sterilization. They are also heavy. Delamination is one of the leading causes of restricting the market's growth. Delamination causes the vials to shed elements like sodium, potassium, and silicon into the contents of the glass and contaminating the vaccine. The new technological advancements with product innovations like valor glass or hybrid vials have enabled manufacturers to overcome the challenges of traditional vial containers. The raging pandemic has created a massive demand for vaccine inoculation, contributing to the development and growth of the global vaccine vial market.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

• Increase in incidence of endemic diseases

The covid-19 pandemic has ravaged nations for the past two years. At the beginning of the pandemic, wearing masks and regular sanitation were the only preventive steps to keep the citizens safe from the disease. As the death toll from the covid increased, governments and the scientific community worldwide expediated vaccines' research, development, trials, approvals, production, and manufacturing. Within two years, the world had three WHO-approved vaccines. The pace of vaccination has retained its speed after the devasting waves nations experienced by being complacent. The increased covid 19 vaccinations will contribute to the growth of the global vaccine vials market. The covid-19 pandemic has highlighted the increased risk of pathogens, bacteria, and viruses in the coming years. It has also shown that vaccinations are the most effective measures in saving the lives of citizens. Therefore, increased awareness among consumers about the benefits of vaccination will drive the market for vaccine vials.

Restraints:

• Lack of infrastructure

Even after successfully completing human trials for domestic vaccines like Covaxin by Bharat Biotech in India, they could not scale their production of vaccines due to a lack of infrastructure. Similarly, the other developing and under-developed nations cannot inoculate their populations due to a lack of adequate and proper infrastructure. The lack of infrastructure will hamper the growth of the global vaccine vials market.

Opportunities:

• Increasing government healthcare expenditure

After witnessing the devasting impacts of covid-19 and the efficiency of vaccines in preventing deaths, governments worldwide have increased their fiscal expenditure on the healthcare sector. The increase in budget will be utilized to develop the healthcare infrastructure, including strengthening research established and pharmaceutical manufacturers. The increase in funding will lead to more research towards understanding future threats from pathogens, viruses, and bacteria, developing better material to produce vaccine vials, and improving medical devices and machinery for efficient production of medical packaging like vials. Such an increase in fiscal expenditure and private investment will provide lucrative opportunities in the global vaccine vials market.

Challenges:

• High cost of supply chain logistics

The latest technologies allow the production of stable vaccines under certain temperature conditions and have a limited life span according to the temperature. Also, the available vaccine vials are primarily made of heavy borosilicate glass. It is breakable and prone to delamination during heat sterilization. Such vulnerabilities of both vaccines and vaccine vials demand their transport under strictly defined conditions. To develop the sophisticated supply chain logistics in-line with the requirements previously mentioned; high capital expenditure is undertaken. The breakable and sensitive nature of vaccines and vaccine vials make them fragile for transportation, thereby, utmost care is taken while transporting them. High capital expenditure is required to establish such sophisticated supply chain logistics making it expensive. The maintenance of the supply chain is also high and hence not feasible for most market players. Therefore, the high cost of supply chain logistics might hamper the market's growth.

Segmentation Analysis:

The global vaccine vials market has been segmented based on type, material, and region.

• The type segment is divided into a single dose and multi-dose. The multi-dose vials segment dominated the market with a market share of around 52% in 2021. The multi-dose vial reduces the cost of the purchase of one vaccine. It also reduces supply chain logistics costs. The reduction in cost enabled by multi-dose vials has increased its popularity in the low- and middle-income countries that struggle financially to acquire proper vaccines for their population. Lower packaging and storage costs translate into more economic benefits for the nation and the manufacturer.
• The material segment is divided into glass and polymer. Over the forecast period, the glass segment is expected to grow at the fastest CAGR of 14.54%. Borosilicate glass has been used for storing vaccines for the past 100 years. It is chemically inert, highly resistant to enzymes, and reasonably resistant to temperature changes. Such properties make it ideal for storing vaccines. New technological advancements have introduced products such as valor, molded, and hybrid glass vials, which are superior to borosilicate glass. Thereby, they help overcome the breakable and heavy nature of borosilicate glass. New research and development in innovating better glass materials will contribute to the growth of the glass vaccine vials market during the forecast period.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest market for the global vaccine vials market, with a 37% share of the market revenue in 2021.

• North America currently dominates the vaccine vials market due to significant market players. The government's renewed focus on developing preventive healthcare measures like vaccines to protect citizens in case of future pandemics and prevalent endemic diseases also contributes to the region's dominance in the global vaccine vials market. Asia-Pacific is expected to rise in the forecast period due to increased government expenditure on healthcare infrastructure and the growing pharmaceutical industry.

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances, and partnerships to improve their market position in the global vaccine vials industry.

Corning, Inc. was awarded USD 204 million in June 2020 to enhance its domestic manufacturing capacity of Corning Valor Glass vials to facilitate the immunization and treatment of billions of patients as a part of the White House's Operation Warp Speed Initiative.

List of Key Market Players:

• Berlin Packaging LLC
• Nipro Corporation
• Cardinal Health Inc.
• Catalent Inc.
• Gerresheimer AG
• DWK Life Sciences GmbH
• SCHOTT AG
• Richland Glass Company Inc.
• Thermo Fisher Scientific Inc.
• Vetter Pharma

Key Target Audience

• Hospitals/Healthcare Providers
• Market Players
• Investors
• End-users
• Government Authorities
• Consulting And Research Firm
• Venture capitalists
• Third-party knowledge providers

Report Description:

• Global Vaccine Vials Market, Industry Analysis, Trends, Analysis and Forecast, 2022 to 2030 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
• 2021 is considered as the base year of the report. 2019 and 2020 are considered as the historic years and 2022 to 2030 are the forecast years. The global vaccine vials market is based on revenue (USD Million). The report incorporates the market study based on revenue. The study covers the market share revenue/market share/volume for each of the segments, regions, and countries catering to the global vaccine vials market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
• The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts across the globe. The research report also delivers an outline of the attractiveness of vaccine vials based on type, material, and regions which are deduced and formulated based on their growth rate (CAGR), market size, and attractiveness by analyzing the present and prospects to fathom market growth and development in future.
• The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to the global vaccine vials market. This offers vital and in-depth insights to depict the overall market scenario.
• The report offers the detailed study for the company profiles of key organizations operating in the global vaccine vials market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario.
• The report provides an elaborative assessment of the porter's five forces analysis coupled with SWOT analysis to provide business related data and informations. Porter's five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company's growth and development to sustain and survive in the long run.
• Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors.
• Potential growth prospects along with the penetration rate analysis of the product (market related, i.e., global vaccine vials market) are covered to comprehend the adoption rate and evaluate the market size.